subject area of
- Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision Academic Article
- Anti-allergic therapies: effects on eosinophil progenitors Academic Article
- Antiallergic and antihistaminic effect of two extracts ofCapparis spinosa L. flowering buds Academic Article
- Clinical consequences of mast cell heterogeneity Academic Article
- Clinical outcomes and adverse effect monitoring in allergic rhinitis Academic Article
- Comment on: Are intranasal corticosteroids all equally consistent in managing ocular symptoms of seasonal allergic rhinitis? Academic Article
- Comparison of the Effect of Low-Dose Ciclesonide and Fixed-Dose Fluticasone Propionate and Salmeterol Combination on Long-term Asthma Control Academic Article
- Delivery of Ketotifen Fumarate by Commercial Contact Lens Materials Academic Article
- EAACI/GA²LEN/EDF/WAO guideline: management of urticaria Academic Article
- Effectiveness of desloratadine 5 mg once daily in patients with symptoms of seasonal allergic rhinitis: Results of a Canadian multicenter, open-label trial Academic Article
- Effects of intranasal fluticasone and salmeterol on allergen-induced nasal responses Academic Article
- Efficacy and acceptability of nedocromil sodium 2% and olopatadine hydrochloride 0.1% in perennial allergic conjunctivitis Academic Article
- Efficacy and safety of Tripterygium wilfordii hook F for chronic urticaria: a systematic review and meta-analysis Academic Article
- First-line treatment of seasonal (ragweed) rhinoconjunctivitis. A randomized management trial comparing a nasal steroid spray and a nonsedating antihistamine. Academic Article
- Fluticasone furoate nasal spray consistently and significantly improves both the nasal and ocular symptoms of seasonal allergic rhinitis: a review of the clinical data Academic Article
- Fluticasone furoate nasal spray is the only intranasal corticosteroid to reduce the ocular symptoms of seasonal allergic rhinitis consistently Academic Article
- Haemopoietic mechanisms in nasal polyposis and asthma Academic Article
- Incidence of COVID-19 in Patients With Chronic Idiopathic Urticaria and Asthma on Omalizumab: A Multicentre Retrospective Cohort Study Academic Article
- MP-AzeFlu in Moderate-to-Severe Allergic Rhinitis: A Literature Review Academic Article
- Nedocromil sodium in golfers with seasonal allergic conjunctivitis Academic Article
- Omalizumab for asthma and allergic bronchopulmonary aspergillosis in adults with cystic fibrosis Academic Article
- Pharmacological regulation of mediator release from human mast cells Academic Article
- Rapid Effect of Inhaled Ciclesonide in Asthma Academic Article
- Role of mast cells in intestinal mucosal function: studies in models of hypersensitivity and stress Academic Article
- Sputum Eosinophils and the Response of Exercise-Induced Bronchoconstriction to Corticosteroid in Asthma Academic Article
- Supplementation of fexofenadine therapy with nedocromil sodium 2% ophthalmic solution to treat ocular symptoms of seasonal allergic conjunctivitis Academic Article
- TGF-β, Eosinophils and IL-13 in Allergic Airway Remodeling: A Critical Appraisal with Therapeutic Considerations Academic Article
- The Back to School asthma study: the effect of montelukast on asthma burden when initiated prophylactically at the start of the school year Academic Article
- The current burden of allergic rhinitis amongst primary care practitioners and its impact on patient management Academic Article
- The effect of IVX-0142, a heparin-derived hypersulfated disaccharide, on the allergic airway responses in asthma Conference Paper
- Twice-daily and once-daily nedocromil sodium 2% ophthalmic solution for the treatment of seasonal allergic conjunctivitis Academic Article